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ABSTRACT 
This study was carried out to determine the molecular analysis of antibiotic resistance 
among the clinical isolates of Pseudomonas aeruginosa. For this study, 54 P. aeruginosa 
isolates were obtained from blood, skin, pus, respiratory, eyes, urine and sputum of both 
paediatric and adult patients. Antibiotic sensitivity analysis was carried out using showed 
Quinolone (Ciprofloxacin) to be the most active antimicrobial agents with 83.34 % 
susceptibility followed by imipenem (81.49%), aminoglycosides (amikacin,74.08% and 
gentamicin, 72.23%) and the beta- lactams (cefepime 62.97%, ceftazidime (15%) and 
amikacine (14%). Among all the P. aeruginosa isolates, 29% of the strains were resistant 
to one antibiotic, 20% strains were resistant to two antibiotics and 51% were multidrug 
resistance. All the 54 strains of P. aeruginosa were subjected to MIC determination for 
ceftazidime and piperacillin by E-test. Piperacillin and ceftazidime showed the maximum 
number of resistance against P. aeruginosa 50% and 29.63% respectively. Among all the 
P. aeruginosa isolates, 12.97% were ESBL positive in phenotypic test whereas the 
11.12% were found positive using E-test. But none of the isolates were found to produce 
MBLs. All these isolates were examined for the production of plasmid and were further 
analysed. Supercoil DNA marker was used to determine the plasmid sizes. It was used in 
electrophoresis gel each time along with the plasmids as molecular weight marker. 
Plasmid profiling analysis shown that, DNA marker was used to estimate the plasmid size 
and was used as molecular weight markers in each gel running. Plasmids were detected in 
10 isolates with the POR of (18.51 %) by using Close and Rodriguez with modification 
(1982) and QIAprep Spin Kit. The overall sizes of the plasmid DNA range from the 
lowest 1.8 kb to the highest 14 kb. These 10 isolates appear to harbor 1 or more plasmids 
with the maximum of 4 plasmids. Various plasmid profiles were observed in the isolates. 
The plasmid analyses revealed that detectable plasmids in 10 (29.42%) out of the 34 
selected multi-drug resistant P. aeruginosa isolates. Twenty four of the isolates possessed 
no plasmids, 3 isolates possessed single sized plasmids (3400bp- 4600bp) while 3 isolates 
had four plasmids with sizes from (1800bp- 5800bp). Four isolates which had 2 plasmids 
size of (220bp-14000bp) respectively. PCR were used to detect the ESBL genes. In this 
study, we examined the molecular type of blaSHV, SHV, 7EMand CTX-M derived ESBL 
variants produced by clinical P. aeruginosa isolates. We identified the strains carrying 
blaSHV and SHV genes by PCR test and confirmed the results by nucleotide sequencing. 
Polymerase chain reaction used in this study proved to be rapid reproducible and specific. 
We have found that 6 P. aeruginosa isolates carried blaSHV gene whereas 2 P. 
aeruginosa isolates carried SHV gene. Polymerase chain reaction produces a fragment of 
200bp of blaSHV gene and 475bp of SHV gene respectively. ESBL positive isolates were 
found to harbour 1 or more plasmids. But TEM and CTX-M genes were not found in all 
the ESBL positive strains. The SHV & blaSHV genes were amplified by PCR. 
Approximately, 10-12 PCR reaction was carried out to have adequate amount of gene for 
sequencing and combined together to pool and purified by PCR purification kit. The 
purified product for sequencing service was sent to Medigene Sdn Bhd Selangor, 
Malaysia. The sequencing result was analysed online using NCBI and BLAST software. 
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